Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Astex Pharmaceuticals, Inc.
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Titan Pharmaceuticals